Abstract

A thermostable β-1,3-galactosidase from Marinomonas sp. BSi20414 was successfully heterologously expressed in Escherichia coli BL21 (DE3), with optimum over-expression conditions as follows: the recombinant cells were induced by adding 0.1 mM of IPTG to the medium when the OD600 of the culture reached between 0.6 and 0.9, followed by 22 h incubation at 20 °C. The recombinant enzyme β-1,3-galactosidase (rMaBGA) was further purified to electrophoretic purity by immobilized metal affinity chromatography and size exclusion chromatography. The specific activity of the purified enzyme was 126.4 U mg−1 at 37 °C using ONPG (o-nitrophenyl-β-galactoside) as a substrate. The optimum temperature and pH of rMaBGA were determined as 60 °C and 6.0, respectively, resembling with its wild-type counterpart, wild type (wt)MaBGA. However, rMaBGA and wtMaBGA displayed different thermal stability and steady-state kinetics, although they share identical primary structures. It is postulated that the stability of the enzyme was altered by heterologous expression with the absence of post-translational modifications such as glycosylation, as well as the steady-state kinetics. To evaluate the potential of the enzyme in synthesis of galactooligosaccharides (GOS), the purified recombinant enzyme was employed to catalyze the transgalactosylation reaction at the lab scale. One of the transgalactosylation products was resolved as 3′-galactosyl-lactose, which had been proven to be a better bifidogenic effector than GOS with β-1,4 linkage and β-1,6 linkages. The results indicated that the recombinant enzyme would be a promising alternative for biosynthesis of GOS mainly with β-1,3 linkage.

Highlights

  • Galactooligosaccharides (GOS) are non-digestible oligosaccharides composed of 3–10 galactosyl groups and a terminal glucose [1]

  • The recombinant plasmid was transformed into E. coli DH5α and the positive clones were picked for sequencing

  • BSi20414 was successfully heterologously expressed in Escherichia coli BL21 (DE3), with optimized over-expression conditions

Read more

Summary

Introduction

Galactooligosaccharides (GOS) are non-digestible oligosaccharides composed of 3–10 galactosyl groups and a terminal glucose [1]. As an important type of dietary supplement, GOS is difficult to digest by the gastrointestine directly, whereas it can stimulate the growth of the prebiotics inhabited in the intestine, such as Lactobacillus and Bifidobacteria, rather than maleficent bacteria [2]. To provide sufficient GOS for humans, chemical and enzymatic approaches have been developed to synthesis of GOS in practice [5]. Because of a lack of specificity of the product and the extreme condition for hydrolysis of lactose to generate monosaccharides, chemical methods are not utilized on a large scale. Enzymatic synthesis of GOS exhibits good stereoselectivity and

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call